Inactive Instrument

Calendar Biovica International AB (publ) Nasdaq Stockholm

Equities

SE0008613731

Chart calendar Biovica International AB (publ)

c3067.JOalHauz65dsIYXNSRdMS1vR9cOiz83pj17ywvobnfo.a4HVdNr5nKYPUvOdKFgpChelpKbF-aja6xyQm6Mu1ItPs_ZW7ICZ4ARiwA~2cae3d1435a60701669f0b54583dd97c

Upcoming events on Biovica International AB (publ)

2024-06-17 Q4 2024 Earnings Release Pre-market
2024-08-27 Q1 2025 Earnings Release (Projected)
2024-12-12 Q2 2025 Earnings Release (Projected)
2025-03-12 Q3 2025 Earnings Release (Projected)
2025-06-17 Q4 2025 Earnings Release (Projected)

Past events on Biovica International AB (publ)

2024-03-14 10:00 am Q3 2024 Earnings Call
2024-03-14 03:00 am Q3 2024 Earnings Release
2023-12-06 09:00 am Carlsquare Investor Day
2023-12-04 San Antonio Breast Cancer Symposium
2023-11-28 09:00 am Q2 2024 Earnings Call
2023-11-28 02:00 am Q2 2024 Earnings Release
2023-11-23 08:00 am Extraordinary Shareholders Meeting
2023-09-06 09:00 am Q1 2024 Earnings Call
2023-09-06 02:00 am Q1 2024 Earnings Release
2023-09-05 04:00 am Annual General Meeting
2023-06-21 09:00 am Q4 2023 Earnings Call
2023-06-20 Q4 2023 Earnings Release Pre-market
2023-05-17 07:00 am Extraordinary Shareholders Meeting
2023-03-17 10:00 am Q3 2023 Earnings Call
2023-03-16 03:20 am Q3 2023 Earnings Release
2022-12-14 Interim 2023 Earnings Release Pre-market
2022-12-08 06:00 pm San Antonio Breast Cancer Symposium - Poster P5-02-27
2022-11-23 Redeye Life Science Day
2022-11-23 12:00 am Investor Meeting
2022-11-21 SEB Healthcare Seminar

Annual results

Fiscal PeriodApril 2019 2020 2021 2022 2023 2024
Net sales
Million SEK
Released
Forecast
Spread
3,01
3,10
-3.06%
1,67
3,00
-44.3%
2,08
3,00
-30.77%
2,05
1,00
104.5%
3,38
5,00
-32.34%

10,0

EBITDA
Million SEK
Released
Forecast
Spread
-18,7
-16,0
-16.86%
-25,6
-32,2
20.23%
-34,0
-34,0
-0.11%
-53,7
-48,0
-11.8%
-102
-86,5
-18.15%

-106

EBIT
Million SEK
Released
Forecast
Spread
-21,7
-20,0
-8.59%
-29,8
-38,0
21.54%
-40,2
-40,0
-0.45%
-60,1
-55,0
-9.27%
-110
-95,0
-16.21%

-116

Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
-21,5
-19,0
-13.28%
-30,3
-37,7
19.74%
-39,4
-40,0
1.53%
-60,0
-45,5
-31.78%
-111
-95,0
-16.51%

-113

Net income
Million SEK
Released
Forecast
Spread
-21,6
-19,0
-13.45%
-30,3
-28,4
-6.75%
-39,5
-40,0
1.3%
-60,0
-37,1
-61.68%
-110
-94,8
-16.59%

-115

EPS
SEK
Released
Forecast
Spread
-1,23
-1,10
-11.82%
-1,29
-1,60
19.38%
-1,39
-1,42
2.11%
-2,11
-1,48
-42.59%
-3,18
-2,31
-37.95%

-13,0

Announcement Date14/06/1905/06/2017/06/2116/06/2221/06/23-

Quarterly results

Fiscal PeriodApril 2022 Q3 2022 Q4 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million SEK
Released
Forecast
Spread



1,08








0,59
2,00
-70.65%
1,75
2,00
-12.3%
2,56
4,00
-35.93%
1,08
9,00
-88.06%

5,00













EBITDA
Million SEK
Released
Forecast
Spread
-12,9
-11,1
-15.73%
-17,3





-27,2
-20,0
-36.2%
-35,2
-23,0
-53.27%
-29,8
-28,0
-6.58%
-22,9
-26,0
11.84%
-25,5
-27,0
5.44%

-27,7













EBIT
Million SEK
Released
Forecast
Spread
-14,4
-11,1
-29.44%
-19,1





-29,3
-22,0
-33.08%
-37,2
-25,0
-49.13%
-32,2
-30,0
-7.31%
-25,3
-29,0
12.7%
-27,8
-28,5
2.29%

-30,4













Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
-14,3
-11,3
-27.31%
-19,1
-14,3
-33.58%



-29,2
-22,0
-32.64%
-37,2
-23,0
-61.75%
-31,9
-25,0
-27.78%
-23,8
-32,0
25.71%
-27,6
-35,0
21.19%

-34,3


-18,6


-18,5


-18,9


-14,9

Net income
Million SEK
Released
Forecast
Spread
-14,3
-11,3
-27.34%
-19,1
-14,3
-33.46%
-23,3


-28,5
-22,0
-29.72%
-37,7
-22,9
-64.29%
-32,3
-24,8
-30.04%
-25,7
-31,7
18.86%
-27,3
-35,1
22.12%

-34,3


-18,6


-18,5


-18,9


-14,9

EPS
SEK
Released
Forecast
Spread
-0,50
-0,31
-60.13%
-0,67
-0,40
-69.17%
-0,81


-0,64
-0,60
-6.67%
-0,81
-0,45
-79.66%
-0,70
-0,30
-133.33%
-0,56
-0,30
-86.67%
-0,44
-0,58
24.63%

-0,40


-0,22


-0,20


-0,19


-0,15

Announcement Date15/03/2216/06/2215/12/2216/03/2321/06/2306/09/2328/11/2314/03/24-----
  1. Stock Market
  2. Equities
  3. BIOVIC B Stock
  4. Stock
  5. Calendar Biovica International AB (publ)